132 related articles for article (PubMed ID: 33388282)
1. Changes in functional status associated with radiation for prostate cancer in older veterans.
Ursem C; Diaz-Ramirez LG; Boscardin J; Lee S
J Geriatr Oncol; 2021 Jun; 12(5):808-812. PubMed ID: 33388282
[TBL] [Abstract][Full Text] [Related]
2. Charlson Comorbidity score influence on prostate cancer survival and radiation-related toxicity.
Ghanem AI; Khalil RM; Khedr GA; Tang A; Elsaid AA; Chetty IJ; Movsas B; Elshaikh MA
Can J Urol; 2020 Apr; 27(2):10154-10161. PubMed ID: 32333734
[TBL] [Abstract][Full Text] [Related]
3. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
Singh N; Singh PS; Aggarwal AN; Behera D
Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
[TBL] [Abstract][Full Text] [Related]
5. Age, comorbidity, life expectancy, and pulmonary nodule follow-up in older veterans.
Wong ML; Shi Y; Fung KZ; Ngo S; Elicker BM; Brown JK; Hiatt RA; Tang VL; Walter LC
PLoS One; 2018; 13(7):e0200496. PubMed ID: 30044854
[TBL] [Abstract][Full Text] [Related]
6. Influence of the technique and comorbidities in hypofractionated radiotherapy for prostate cancer.
Correa R; Navarro I; Lobato M; Otero A; Jerez I; Rico JM; Zapata I; Lupiañez Y; Medina JA; Olmos D; Gómez-Millán J
Clin Transl Oncol; 2020 Mar; 22(3):311-318. PubMed ID: 31721011
[TBL] [Abstract][Full Text] [Related]
7. Impact of comorbidity in elderly prostate cancer patients treated with brachytherapy.
Chiumento C; Fiorentino A; Cozzolino M; Caivano R; Clemente S; Pedicini P; Fusco V
Chin J Cancer Res; 2013 Jun; 25(3):274-80. PubMed ID: 23825903
[TBL] [Abstract][Full Text] [Related]
8. Association of functional status and treatment choice among older men with prostate cancer in the Medicare Advantage population.
Jacobs BL; Lopa SH; Yabes JG; Nelson JB; Barnato AE; Degenholtz HB
Cancer; 2016 Oct; 122(20):3199-3206. PubMed ID: 27379732
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Charlson Comorbidity Index in acutely hospitalized elderly adults: a prospective cohort study.
Frenkel WJ; Jongerius EJ; Mandjes-van Uitert MJ; van Munster BC; de Rooij SE
J Am Geriatr Soc; 2014 Feb; 62(2):342-6. PubMed ID: 24521366
[TBL] [Abstract][Full Text] [Related]
10. Impact of age and comorbidity on colorectal cancer screening among older veterans.
Walter LC; Lindquist K; Nugent S; Schult T; Lee SJ; Casadei MA; Partin MR
Ann Intern Med; 2009 Apr; 150(7):465-73. PubMed ID: 19349631
[TBL] [Abstract][Full Text] [Related]
11. Impact of Malnutrition on Physical, Cognitive Function and Mortality among Older Men Living in Veteran Homes by Minimum Data Set: A Prospective Cohort Study in Taiwan.
Chen LY; Liu LK; Hwang AC; Lin MH; Peng LN; Chen LK; Lan CF; Chang PL
J Nutr Health Aging; 2016 Jan; 20(1):41-7. PubMed ID: 26728932
[TBL] [Abstract][Full Text] [Related]
12. Impact of Charlson comorbidity index varies by age in patients with prostate cancer treated by radical prostatectomy: a competing risk regression analysis.
Lee JY; Lee DH; Cho NH; Rha KH; Choi YD; Hong SJ; Yang SC; Cho KS
Ann Surg Oncol; 2014 Feb; 21(2):677-83. PubMed ID: 24145996
[TBL] [Abstract][Full Text] [Related]
13. Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer.
Lehtonen M; Heiskanen L; Reinikainen P; Kellokumpu-Lehtinen PL
BMC Cancer; 2020 Apr; 20(1):324. PubMed ID: 32295542
[TBL] [Abstract][Full Text] [Related]
14. Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy.
Feagins LA; Kim J; Chandrakumaran A; Gandle C; Naik KH; Cipher DJ; Hou JK; Yao MD; Gaidos JKJ
Inflamm Bowel Dis; 2020 Apr; 26(5):728-733. PubMed ID: 31412114
[TBL] [Abstract][Full Text] [Related]
15. A prospective clinical and transcriptomic feasibility study of oral-only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity.
Onderdonk BE; Dorn PL; Martinez C; Arif F; Cloutier D; Antic T; Golden DW; Karrison T; Pitroda SP; Szmulewitz RZ; Liauw SL
Cancer; 2021 Aug; 127(15):2631-2640. PubMed ID: 33882144
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity, use of common medications, and risk of early death in patients with localized or locally advanced prostate cancer.
Nieder C; Dalhaug A; Pawinski A; Aandahl G; Norum J
ScientificWorldJournal; 2011 Jun; 11():1178-86. PubMed ID: 21666987
[TBL] [Abstract][Full Text] [Related]
17. Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer.
Justice AC; Tate JP; Howland F; Gaziano JM; Kelley MJ; McMahon B; Haiman C; Wadia R; Madduri R; Danciu I; Leppert JT; Leapman MS; Thurtle D; Gnanapragasam VJ
Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38171965
[TBL] [Abstract][Full Text] [Related]
18. Use of the Charlson combined comorbidity index to predict postradiotherapy quality of life for prostate cancer patients.
Wahlgren T; Levitt S; Kowalski J; Nilsson S; Brandberg Y
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):997-1004. PubMed ID: 20932681
[TBL] [Abstract][Full Text] [Related]
19. Charlson comorbidity index is an important prognostic factor for long-term survival outcomes in Korean men with prostate cancer after radical prostatectomy.
Lee JY; Lee DH; Cho NH; Rha KH; Choi YD; Hong SJ; Yang SC; Cho KS
Yonsei Med J; 2014 Mar; 55(2):316-23. PubMed ID: 24532498
[TBL] [Abstract][Full Text] [Related]
20. Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study.
Meert G; Kenis C; Milisen K; Debruyne PR; De Groof I; Focan C; Cornélis F; Verschaeve V; Bachmann C; Bron D; Den Bulck HV; Schrijvers D; Langenaeken C; Specenier P; Jerusalem G; Praet JP; Lobelle JP; Flamaing J; Wildiers H; Decoster L
J Geriatr Oncol; 2022 Nov; 13(8):1162-1171. PubMed ID: 36085275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
